ALTEOGEN Market Cap

ALTEOGEN has a market cap or net worth of 20.94 trillion as of April 17, 2025. Its market cap has increased by 100.85% in one year.

Market Cap

20.94T

Enterprise Value

20.86T

Revenue

102.85B

Ranking

n/a

PE Ratio

336.45

Stock Price

393,000.00

Market Cap Chart

Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 20.94T, an increase of 17,360.60%. That is a compound annual growth rate of 64.62%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2025	20.94T	26.98%
Dec 30, 2024	16.49T	221.05%
Dec 28, 2023	5,137.84B	160.78%
Dec 29, 2022	1,970.17B	-38.41%
Dec 30, 2021	3,198.72B	-36.62%
Dec 30, 2020	5,046.50B	442.81%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.59T
Celltrion	34.26T
Yuhan	8,492.40B
SK Biopharmaceuticals	8,089.76B
HLB Co., Ltd.	7,094.07B
LigaChem Biosciences	3,972.88B
PharmaResearch	3,807.81B
Sam Chun Dang Pharm.	3,635.14B

Market Cap Rankings